Page last updated: 2024-10-22

acetyl-dl-leucine and Spinocerebellar Ataxias

acetyl-dl-leucine has been researched along with Spinocerebellar Ataxias in 1 studies

acetylleucine: used for treating vestibular-related imbalance and vertigo

Spinocerebellar Ataxias: A group of predominately late-onset, cerebellar ataxias which have been divided into multiple subtypes based on clinical features and genetic mapping. Progressive ataxia is a central feature of these conditions, and in certain subtypes POLYNEUROPATHY; DYSARTHRIA; visual loss; and other disorders may develop. (From Joynt, Clinical Neurology, 1997, Ch65, pp 12-17; J Neuropathol Exp Neurol 1998 Jun;57(6):531-43)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feil, K1
Adrion, C1
Teufel, J1
Bösch, S1
Claassen, J1
Giordano, I1
Hengel, H1
Jacobi, H1
Klockgether, T1
Klopstock, T1
Nachbauer, W1
Schöls, L1
Stendel, C1
Uslar, E1
van de Warrenburg, B1
Berger, I1
Naumann, I1
Bayer, O1
Müller, HH1
Mansmann, U1
Strupp, M1

Trials

1 trial available for acetyl-dl-leucine and Spinocerebellar Ataxias

ArticleYear
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
    BMC neurology, 2017, Jan-10, Volume: 17, Issue:1

    Topics: Adult; Cerebellar Ataxia; Cross-Over Studies; Double-Blind Method; Humans; Leucine; Psychiatric Stat

2017